Drug Trials Snapshots: NGENLA (somatrogon-ghla)

NGENLA is a human growth hormone for the treatment of children 3 years of age and older who are not growing because they have growth hormone deficiency (GHD). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ngenla GHD is a condition in which the body does not produce enough growth hormone (GH). Symptoms of GHD in children include poor growth and short stature.